A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Elon Musk’s X ordered to pay over $1m in legal fees for laid off Twitter execs
India landed on the Moon for less than it cost to make Interstellar
ICBC partners wary to resume trading with bank after cyberattack - Bloomberg News
Nepali sherpa becomes world’s second person to scale Everest 26 times
Thales awarded multi-year contract for new generation US Passport eCovers
Microsoft under European antitrust investigation over Teams
Robots take questions at Geneva press conference, say they could be better leaders than humans
Reddit's fight with its most powerful users enters new phase as blackout continues